Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
|
|
Reuters NewMedia - Wednesday, April 21, 1999
"Twenty years into the epidemic, it is alarming that AIDS is expanding three times faster than the funding to control it," Dr. Peter Piot, executive director of the United Nations programme UNAIDS, said in a statement.
"Weighed against the global catastrophe of the AIDS epidemic, the level of spending for HIV prevention around the world is minimal."
Between 1990 and 1997, the number of people infected with the virus that causes AIDS tripled from 9.8 million to 30.3 million, the study found. During that time, funding for HIV and AIDS prevention grew from $165 million to $273 million.
In 1999, 47 million people are estimated to have HIV -- nearly five times as many as in 1990 -- but the $350 million spent to control it is only slightly more than double the 1990 funding level.
"Donor nations must realise that their substantial investments towards improving conditions in developing nations will be effectively obliterated unless more is invested in fighting AIDS -- the single greatest threat to global development today," Piot said.
The report by UNAIDS and researchers at Harvard University found that the United States is the biggest spender in the AIDS field, contributing $135.2 million in 1997, the last year for which a breakdown of funding is available.
But the United States and other industrialised nations spend less than 1 percent of their overseas development budgets on AIDS, the report said.
The Netherlands and Norway spend the highest percentage of their gross national products on AIDS, the report found.
990421
RE990405
Copyright © 1999 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .